ACA Issue Briefs provide rapid reaction to breaking arms control events and analyze key nuclear/chemical/biological/conventional arms issues. They are available for quotation by the media.
Iran and the P5+1 are working to negotiate a comprehensive agreement by Nov. 24 that ensures that Iran does not use its nuclear program to build nuclear weapons.
The next test of the U.S. Ground-Based Interceptor (GBI) system will occur "very soon," Admiral James Winnefeld, Vice Chairman of the Joint Chiefs of Staff, said May 28. And if that test is a success, he said, the Pentagon plans to add 14 interceptors to the 30 deployed in Alaska and California by 2017, increasing the total by almost 50 percent. This expansion will cost about $1 billion.
Throughout the Cold War years and beyond, the United States and Russia have overcome ideological differences to reach legally binding, verifiable agreements to control and reduce their massive nuclear weapon stockpiles, including the 1987 Intermediate-Range Nuclear Forces (INF) Treaty, the 1991 Strategic Arms Reduction Treaty (START), and the 2010 New START Treaty.
In March, the Obama administration announced it would delay key elements of its "3+2" plan to rebuild the U.S. stockpile of nuclear warheads amidst growing concern about the program's high cost and its technically ambitious approach.
As President Vladimir Putin exploits the results of Crimea's illegitimate referendum and as Russian troops gather on Ukraine's eastern border, alarms have been raised in the West that U.S.-Russian relations are on the verge of plummeting to Cold War levels.
Last week, negotiators from the United States, its "P5+1" partners (China, France, Germany, Russia, and the United Kingdom), and Iran agreed to a framework and timetable to guide the talks on a "comprehensive solution that would ensure Iran's nuclear programme will be exclusively peaceful."
The United States plans to spend at least $355 billion to maintain and rebuild its nuclear arsenal over the next decade, according to a new report by the nonpartisan Congressional Budget Office (CBO). Over the next 30 years, the bill could add up to $1 trillion, according to another independent estimate.
In nuclear negotiations, as in medicine, the first principle is: "Do no harm." Yet a bill authored by Sen. Robert Menendez (D-NJ) and co-sponsored by 58 of his colleagues, threatens to pull the plug on the patient just as the Iran nuclear negotiations are entering their most delicate phase.
The "Iran Nuclear Weapon Free Act" (S. 1881), introduced in the Senate on December 19 by Sens. Menendez (D-N.J.) and Kirk (R-Ill.), threatens to derail the breakthrough agreement that Iran and the P5+1 reached in Geneva on November 24 that will pause Iran's most worrisome nuclear activities in exchange for limited and reversible sanctions relief.
After years of on-and-off negotiations, the latest round of P5+1 (China, France, Russia, the United Kingdom, the United States, plus Germany) talks with Iran has finally yielded an important breakthrough: a "first-phase" deal to constrain Iran's nuclear potential and to "reach a mutually agreed long-term comprehensive solution that would ensure that Iran's nuclear programme will be exclusively peaceful."